TORONTO & SAN FRANCISCO, February 14, 2024 Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel first-in-class medicines for unmet needs in cancer, today announced the formation of a Scientific Advisory Board comprised of prominent oncology leaders and drug developers. The SAB will work closely with Treadwell to advance the company’s pipeline of small molecules, biologics and cell therapies.
Recognizing and Celebrating Outstanding Contributions to the Canadian Cancer Research Community lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Prof. Tak Wah Mak, the Academician of the US National Academy of Sciences, invited by USTC, came for a visit and attended Master Forum. This world-renowned immunologist and oncologist delivered a fascinating lecture on future anti-tumor therapies, ti